Imagine a cornerstone of American public health teetering on the edge of collapse, shaken by violence at its headquarters and threatened by massive budget cuts, leaving many to wonder about the future of disease prevention in the nation. The Centers for Disease Control and Prevention (CDC), an
In a significant stride toward better outcomes for patients grappling with one of the most aggressive forms of breast cancer, a groundbreaking clinical study from South Korea has emerged as a beacon of hope for those affected. Known as the MIRINAE trial, or KCSG-BR18-21, this phase II randomized
In a stunning disclosure that has sent shockwaves through the scientific and political spheres, the Government Accountability Office (GAO) has concluded that the administration of former President Donald Trump acted unlawfully by withholding $8 billion in funding designated for the National
In a remarkable turn of events for the biopharmaceutical industry, Jazz Pharmaceuticals (NASDAQ:JAZZ) has captured significant market attention with a sharp rise in its stock price, fueled by a pivotal regulatory achievement that marks a turning point for the company. This surge, recorded at 4.8%
In a region where tropical climates foster the spread of vector-borne diseases, Cuba stands at the forefront of a persistent public health challenge, grappling with multiple viral outbreaks that threaten the well-being of its population. Recent updates from Francisco Durán García, the national
In a world where neonatal brain injuries can alter the course of a child’s life before it even truly begins, a groundbreaking development in medical science offers a glimmer of hope for families facing such challenges with the potential to transform pediatric care. Researchers at Wilhelmina
